Bcl-X L mice display a similar neurodevelopmental phenotype as rb, DNA ligase IV, and XRCC4 mutant embryos, suggesting that endogenous Bcl-X L expression may protect immature neurons from death caused by DNA damage and/or cell cycle dysregulation. To test this hypothesis, we generated bcl-x/p53 double mutants and examined neuronal cell death in vivo and in vitro. Bcl-X L -deficient primary telencephalic neuron cultures were highly susceptible to the apoptotic effects of cytosine arabinoside (AraC), a known genotoxic agent. In contrast, neurons lacking p53, or both Bcl-X L and p53, were markedly, and equivalently, resistant to AraC-induced caspase-3 activation and death in vitro indicating that Bcl-X L lies downstream of p53 in DNA damage-induced neuronal death. Despite the ability of p53 deficiency to protect Bcl-X Ldeficient neurons from DNA damage-induced apoptosis in vitro, p53 deficiency had no effect on the increased caspase-3 activation and neuronal cell death observed in the developing Bcl-X L -deficient nervous system. These findings suggest that Bcl-X L expression in the developing nervous system critically regulates neuronal responsiveness to an apoptotic stimulus other than inadequate DNA repair or cell cycle abnormalities.
Introduction
Normal nervous system development requires the coordinated action of apoptotic stimuli with intracellular molecular regulators of neuronal death. 1 The important role of neurotrophic factors in matching the size of developing neuronal populations with the extent of their post-synaptic targets has been well described. 2 However, only recently have other apoptotic stimuli been recognized as affecting mammalian nervous system development. 3, 4 The protein product of the tumor suppressor gene retinoblastoma (rb) is an important regulator of the cell cycle. 5, 6 The Rbdeficient nervous system displays numerous ectopic mitotic figures and many neurons undergoing apoptotic cell death. These findings suggest that failure of immature neurons to appropriately withdraw from the cell cycle could be an important stimulus for naturally-occurring neuronal cell death. 7 Similarly, studies of mice with targeted genedisruptions in XRCC4 and DNA ligase IV have demonstrated that inadequate repair of DNA double strand breaks produces extensive death of neurons in the developing nervous system. 8, 9 The intracellular apoptotic effector mechanism for both cell cycle dysregulation and DNA damage appears to involve p53. p53 deficiency completely prevented the increased neuronal cell death observed in XRCC4-deficient and DNA ligase IV-deficient mice and it rescued Rb-deficient neurons in the central, but not peripheral, nervous system from premature death. 10 ± 13 Studies of`double-knockout' mice have also shown involvement of ATM in the apoptosis of DNA ligase IVdeficient neurons and of caspase-3 in the death of Rbdeficient peripheral neurons. 14, 15 In total, these studies have provided insights into the potential stimuli and molecular pathways regulating naturally-occurring neuronal cell death.
Targeted gene disruption of the anti-apoptotic Bcl-2 family member, Bcl-X L , resulted in extensive apoptotic death of immature neurons throughout the developing central and peripheral nervous systems in a pattern similar to that observed in XRCC4-, DNA ligase IV-, and Rbdeficient mice. 16 Like Rb-deficient peripheral neurons, Bcl-X L -deficient neurons were rescued from increased apoptosis by caspase-3 deficiency suggesting a possible link between cell cycle dysregulation, Bcl-X L , and caspase-3-dependent death pathways. 17 In a previous study of primary telencephalic neuronal cultures, we found increased caspase-3 activation and cell death in cytosine arabinoside (AraC)-exposed Bcl-X L -deficient cells; in contrast, p53-deficient neurons were remarkably resistant to the effects of AraC. 18 In an attempt to identify the apoptotic signals regulating naturally-occurring neuronal cell death and to define the molecular pathway of AraC-induced telencephalic neuron death, we generated bcl-x 7/7 /p53 7/7 mice and examined the effect of p53 deficiency on Bcl-X Ldeficient neurons in vivo and in vitro. Our data suggest that under normal developmental conditions, cell cycle dysregulation and inadequate DNA repair are relatively minor apoptotic stimuli in the central nervous system and that Bcl-X L expression is critical for preventing immature neuron apoptosis caused by an undefined developmental signal(s) through a p53-independent pathway.
Results
p53 de®ciency fails to rescue Bcl-X L -de®cient mice from embryonic lethality
To determine whether p53 deficiency is capable of preventing embryonic lethality in bcl-x 7/7 mice, bcl-x +/7 /p53 +/7 mice were interbred and surviving mice were genotyped at weaning. Genotypic analysis of 86 offspring revealed no bclx 7/7 mice (expected Mendelian frequency is 1 in 16 assuming no embryonic lethality of either gene disruption or 1 in 13 assuming embryonic lethality of bcl-x 7/7 /p53 +/+ and bcl-x 7/7 /p53 +/7 mice; P40.05). Identical results were obtained when bcl-x +/7 /p53 7/7 mice were interbred (i.e. zero bcl-x 7/7 mice were observed in 24 genotyped offspring; expected frequency is one in four; P40.05). These findings suggest that p53 deficiency is incapable of preventing the hematopoietic and/or hepatic abnormalities that cause the embryonic lethality of Bcl-X L -deficient mice. Bcl-X L -deficient mice die around E13.5 and since p53 deficiency did not rescue the embryonic lethality of Bcl-X L deficiency, we performed in vitro and in vivo studies of bcl-x 7/7 /p53
mice at E12.5.
p53 deficiency protects wild-type and Bcl-X L -deficient telencephalic neurons from AraC-induced death in vitro
The E12.5 telencephalon consists predominantly of neural precursor cells which are unaffected by Bcl-X L deficiency. 16, 17, 19 We have previously shown that wild-type and Bcl-X L -deficient telencephalic cell cultures grown in a chemically defined enriched medium for 48 h consist almost exclusively of post-mitotic neurons and show comparable, low levels of caspase-3 activation and apoptosis at baseline. 19 ± 21 We have also shown that addition of the nucleoside analog, AraC to telencephalic neurons in vitro results in extensive caspase-3 activation and cell death over the subsequent 24 ± 48 h period. 18, 21 This effect is exacerbated in Bcl-X L -deficient and attenuated in p53-deficient telencephalic cultures. 18, 21 p53 has both Bcl-2 family dependent and independent effects; 22 ± 24 we therefore examined the relationship between p53 and Bcl-X L in untreated and AraC exposed (25 mM) telencephalic neuron cultures prepared from control, p53 7/7 , bcl-x 7/7 , and bcl-x 7/7 /p53 7/7 E12.5 mice. In untreated cells, there was no significant difference in baseline viability (93 ± 96%) or CM1 immunoreactivity (1.5 ± 2.7%) between groups (data not shown). Forty-eight hours after exposure of wild-type telencephalic neurons to AraC, the percentage of Figure 1 Quantification of caspase-3 activation and cell viability in AraC exposed control, p53-deficient, Bcl-X L -deficient, and double-deficient telencephalic cells. Primary telencephalic neuron cultures were prepared from E12.5 control and homozygous mutant mice. After 48 h in a chemically-defined enriched media that promotes neuronal differentiation, cells were exposed to AraC (25 mM) for an additional 48 h and the frequency of caspase-3 immunoreactive cells was assessed by CM1 immunostaining. Viability was determined by quantification of total nuclei with Hoechst 33,258 and nonviable nuclei by SYTOX Green labeling. Untreated cultures contained 493% viable cells and 53% caspase-3 immunoreactive cells and there was no difference in these measurements between genotypes (data not shown). AraC exposed control cells showed a significant increase in the number of caspase-3 immunoreactive cells (A) and a decrease in the percentage of viable cells (B). These effects were potentiated in bcl- Figure  1A ,B). Consistent with our previous studies, p53 7/7 neurons showed a marked attenuation and bcl-x 7/7 neurons a significant exacerbation of the effects of AraC on both caspase-3 activation and cell death ( Figure 1A,B) . 18, 21 Telencephalic neurons derived from bcl-x 7/7 /p53 7/7 embryos exhibited dramatic resistance to AraC-induced caspase-3 activation and death, equivalent to that observed in bcl-x +/+ /p53 7/7 telencephalic cultures ( Figure 1A ,B). These findings suggest that AraC triggers a p53-dependent death pathway in telencephalic neurons that engages downstream Bcl-2 family mediated events including caspase-3 activation.
Increased apoptosis in the Bcl-X L -deficient embryonic nervous system is unaffected by p53 deficiency p53 deficiency rescues DNA Ligase IV-and XRCC4-deficient central and peripheral neurons from increased apoptosis during development and it selectively decreases neuronal apoptosis in the Rb-deficient central, but not peripheral, nervous system. To determine if p53 deficiency could similarly protect Bcl-X L -deficient neurons from premature death in vivo, we examined control, bcl-x
, p53 7/7 , and bcl-x 7/7 /p53
mice on E12.5. H and E stained sections of E12.5 control mice showed occasional condensed, pyknotic, and/or fragmented nuclei indicative of naturally-occurring neuronal cell death in the brainstem and spinal cord ( Figure 2A ). Apoptotic nuclear features were more common in Dorsal Root Ganglion (DRG) neurons and quantitation of such nuclei revealed approximately six apoptotic nuclei per 606 microscopic field (Table  1) . Similarly, immunodetection of activated caspase-3-like immunoreactivity in control embryos showed scattered positive cells in the developing central nervous system ( Figure  3A) , and approximately seven immunoreactive cells per 606 microscopic field in the DRG (Table 1) . p53 deficiency by itself had no effect on the frequency of activated caspase-3 immunoreactive cells or apoptotic nuclei in the E12.5 nervous system ( Figures 2B, 3B and Table 1 ). In contrast, a dramatic 
/p53
7/7 mice were H&E stained for quanti®cation of apoptotic nuclei or immunostained with CM1 antiserum for detection of activated caspase-3-like reactivity. The mean number of positive cells and S.E.M. was determined for each group (n=5 per group). A gene dosage effect was not detected for either bcl-x or p53 and therefore, data from +/+ and +/7 embryos were pooled (+/o denotes +/+ and +/7 mice). P40.05 versus bcl-x
Cell Death and Differentiation
Bcl-X L -p53 interactions BJ Klocke et al increase in caspase-3 activation and apoptotic death was observed in both the central and peripheral nervous systems of Bcl-X L -deficient embryos ( Figures 2C, 3C and Table 1 ). If the increased neuronal cell death observed in Bcl-X L -deficient mice was the result of an apoptotic stimulus that engaged a p53-dependent death pathway, we would expect p53 deficiency to alleviate the effects of the bcl-x targeted gene disruption, as it does for DNA ligase IV, XRCC4, and, at least in the central nervous system, rb gene disruptions. We found that bcl-x 7/7 /p53 7/7 mice exhibited a neurodevelopmental phenotype identical to that of bcl-x 7/7 /p53 +/+ mice; i.e. they showed a marked increase in the number of activated caspase-3-immunoreactive and apoptotic neurons in both the central and peripheral nervous systems ( Figures 2D, 3D and Table 1 ). In total, the inability of p53 deficiency to affect caspase-3 activation and neuronal apoptosis in either bcl-x +/+ or bcl-x 7/7 embryos suggests that naturally-occurring neuronal cell death, at least at E12.5, is not critically regulated by a p53-dependent death stimulus nor is the increased neuronal apoptosis observed in the Bcl-X L -deficient central nervous system due to inadequate repair of DNA strand breaks or cell cycle dysregulation since the death promoting effects of these stimuli are prevented by p53 deficiency.
Discussion
The interaction between p53 and the Bcl-2 family is complex, often exhibiting stimulus, cell type, and maturation-specific effects.
18,23 ± 25 p53 and Bcl-2 family members may have entirely dependent or independent effects on cell death; thus, we examined the ability of p53 deficiency to rescue Bcl-X Ldeficient neurons from increased apoptotic death in an in vitro model of DNA damage-induced death and in the developing nervous system in vivo. Consistent with our previous in vitro studies of DNA damage-induced neuronal death, Bcl-X L -deficient neurons showed increased, and p53-deficient neurons decreased, susceptibility to the death promoting effects of AraC, a known genotoxic agent. 18, 21 p53 deficiency completely blocked the increased apoptotic susceptibility of Bcl-X L -deficient neurons to AraC and there was no difference in either caspase-3 activation or extent of death between bcl-x +/+ /p53 7/7 and bcl-x 7/7 /p53 7/7 neurons. These findings suggest that Bcl-X L lies downstream of p53 in the apoptotic pathway of DNA damage-induced death of telencephalic neurons. In combination with previous studies of DNA ligase IV-and XRCC4-deficient mice, the data are also consistent with the hypothesis that endogenous Bcl-X L expression promotes immature neuron survival by allowing adequate time for DNA double strand break repair enzymes to function. To directly test this hypothesis, we generated bcl-x 7/7 /p53 7/7 mice and analyzed caspase-3 activation and neuronal cell death in vivo.
Bcl-X L deficiency is lethal around gestational day 13.5 and bcl-x 7/7 embryos exhibit extensive cell death in the developing hematopoietic and nervous systems. Genotyping of over 100 viable offspring from interbreeding bcl-x +/7 / Bcl-X L -p53 interactions BJ Klocke et al p53 +/7 and/or bcl-x +/7 /p53 7/7 mice failed to produce a single double-deficient mouse indicating that p53 deficiency does not rescue Bcl-X L -deficient mice from embryonic lethality. Targeted disruptions of any of a variety of proapoptotic molecules, bax, apaf-1, caspase-9, and caspase-3, can rescue Bcl-X L -deficient neurons from excess cell death; however, none of these gene disruptions rescue bclx 7/7 embryos from premature lethality. 17, 18, 20, 26 Since the embryonic lethality of Bcl-X L -deficient mice is thought secondary to increased hematopoietic and/or hepatocellular death, not neuronal death, we examined the central and peripheral nervous systems of control, bcl-x 7/7 , p53
and bcl-x 7/7 /p53 7/7 mice at gestational day 12.5. Since Bcl-X L -, DNA ligase IV-and XRCC4-deficient embryos all show increased death of immature neurons, 8, 9 and p53 deficiency abolishes this effect in DNA ligase IVand XRCC4-deficient mice, 10,11 the ability of p53 deficiency to decrease immature neuron death in bcl-x 7/7 embryos would support a role for Bcl-X L in modulating neuronal responsiveness to naturally-occurring DNA damage and double strand break repair. In contrast, an inability of p53 deficiency to affect immature neuron death in bcl-x 7/7 embryos would suggest that a p53-independent developmental stimulus and death pathway is more critically dependent on endogenous Bcl-X L expression. Bcl-X Ldeficient E12.5 mice displayed markedly increased caspase-3 activation and apoptosis in immature neurons throughout the central and peripheral nervous systems while bcl-x +/+ /p53 7/7 embryos appeared similar to wildtype littermates. Examination of bcl-x 7/7 /p53 7/7 E12.5 mice showed a neurodevelopmental phenotype identical with that observed in bcl-x 7/7 /p53 +/+ embryos. Doubledeficient embryos exhibited extensive caspase-3 activation and neuronal cell death in both the central and peripheral nervous systems, equivalent to that observed in bcl-x 7/7 embryos. These data indicate that excess death of Bcl-X Ldeficient neurons in vivo is not dependent on p53 expression nor is it likely to result from inadequate repair of DNA double-strand breaks.
In addition to DNA damage, cell cycle dysregulation is a possible apoptotic stimulus for developing neurons. Like bcl-x, DNA ligase IV, and XRCC4 gene disruptions, rb gene disruption causes increased death of immature neurons in the developing central and peripheral nervous systems. 5, 6 pRb is a key regulator of the cell cycle and Rb-deficient neurons exhibit ectopic mitoses, impaired differentiation, and apoptotic death. Interestingly, the effects of Rb deficiency on central and peripheral neurons appear mediated by distinct apoptotic pathways. p53 deficiency rescues central nervous system Rb-deficient neuronal death, but not peripheral nervous system death, while caspase-3 deficiency rescues peripheral nervous system death but not central nervous system death in Rb-deficient mice. 13, 15 The inability of p53 deficiency to rescue either central or peripheral nervous system death in bcl-x 7/7 embryos suggests that cell cycle dysregulation in the central nervous system is not a major apoptotic stimulus from which Bcl-X L provides protection. In contrast, the ability of caspase-3 deficiency, but not p53 deficiency, to rescue both bcl-x 7/7 and rb 7/7 peripheral neurons from apoptotic death suggests, but does not prove, that cell cycle dysregulation in the peripheral nervous system activates a p53-independent, Bcl-X L -and caspase-3-dependent death pathway. Neurotrophic factors and their receptors play a clear role in regulating survival of synapse-bearing neurons. However unlike the effect of Bcl-X L deficiency, targeted disruptions of neurotrophic factor-related genes have produced relatively limited effects on immature neurons in the developing nervous system. 27, 28 It remains possible that other trophic molecules, such as FGF-2 or IGF-I, are limiting in the developing brain and that endogenous Bcl-X L expression serves an anti-apoptotic function during the maturation of neural precursor cells into synapse-bearing neurons. Alternatively, still to be defined pro-and anti-apoptotic signals may be present in the nervous system that critically regulate expression of Bcl-X L and/or its pro-apoptotic partner, Bax in immature neurons. Identification of such signals will be important for understanding mammalian nervous system development.
Materials and Methods

Generation of bcl-x/p53 mutant mice
The generation and characterization of bcl-x 7/7 mice has been described previously. 16 p53 +/7 mice were purchased from Taconic (Germantown, NY, USA). To produce mice deficient in both Bcl-X L and p53, double heterozygote (bcl-x +/7 /p53 +/7 ) mice were interbred. Alternatively, bcl-x +/7 /p53 7/7 mice were mated with either bcl-x +/7 / 53 +/7 or bcl-x +/7 /p53 7/7 mice. Endogenous and disrupted genes were detected by PCR analysis of tail DNA extracts as previously described. 19, 29 To determine whether the frequency of bcl-x 7/7 / p53 7/7 mice followed predicted Mendelian inheritance, w 2 analysis of contingency tables was used.
Histology and immunohistochemistry
Pregnant mice were anesthetized with methoxyflurane and killed on gestational day 12.5 by cervical dislocation. Embryos (E12.5) were removed and tail and limb samples were taken for DNA extractions and PCR analyses. Whole embryos or embryos without their forebrains, which were used for telencephalic cell cultures, were placed in Bouin's fixative overnight at 48C followed by three washes in 70% ethanol. Tissue was dehydrated, paraffin-embedded, and 4 mm thick sagittal sections were cut. Sections were deparaffinized and hematoxylin and eosin (H&E)-stained as described previously. 20 For immunohistochemistry, deparaffinized sections were incubated overnight at 48C with CM-1, an affinity-purified rabbit polyclonal antiserum, which recognizes the p18 subunit of activated caspase-3, 30 diluted 1 : 40 000 in PBS-blocking buffer (PBS-BB; PBS with 0.1% BSA, 0.3% Triton X-100 and 0.2% nonfat powdered dry milk). Following washes with PBS, sections were incubated with a donkey anti-rabbit horseradish peroxidase-conjugated secondary antiserum (Jackson Immunoresearch, West Grove, PA, USA), diluted 1 : 1000 in PBS-BB, for 1 h at room temperature. Immunostaining was detected using a tyramide signal amplification system (Perkin-Elmer Life Science Products, Boston, MA, USA). Tissue was counterstained with bisbenzimide (0.2 mg/ml; Hoechst 33,258; Sigma, St. Louis, MO, USA) and examined with a Zeiss-Axioskop microscope equipped with epifluorescence. The number of dorsal root ganglion cells with apoptotic nuclear features and CM1 immunoreactivity was assessed in multiple 606 magnification microscopic fields per mouse by an observer blinded to the embryo's genotype. Statistical significance was established using one way analysis of variance and the Tukey test.
Primary telencephalic cultures E12.5 telencephalic cells were dissociated as previously described and plated in a chemically defined serum-free medium containing insulin, transferrin, selenium, progesterone, putrescine, glucose and glutamine 19 followed by incubation at 378C in humidified 5% CO 2 /95% air atmosphere for 48 h. Cells were then placed in fresh medium containing 2% FCS with or without AraC (Sigma) for an additional 48 h. SYTOX green (500 nM; SG; Molecular Probes) was added to label dead cells. Cultures were then fixed with 4% paraformaldehyde (pH=7.4) for 20 min at 48C. Activated caspase-3-like immunoreactivity was detected with CM1 antiserum and tyramide signal amplification techniques (TSA; Perkin-Elmer Life Science Products, Inc.) as previously described. 30 Cells were counterstained with bisbenzimide (Sigma) and visualized on a Zeiss-Axiovert microscope equipped with epifluorescence. Telencephalic cells from each embryo were plated in duplicate wells for each condition and the number of nuclei, CM1 and SG positive cells was counted at 406 magnification from multiple fields in each well. Approximately 150 to 200 nuclei were counted per well and significance was established using the Tukey test of multiple pairwise comparisons.
